V
Vedat Hamuryudan
Researcher at Istanbul University
Publications - 177
Citations - 6934
Vedat Hamuryudan is an academic researcher from Istanbul University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 39, co-authored 156 publications receiving 6251 citations. Previous affiliations of Vedat Hamuryudan include VU University Medical Center & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.
Emire Kural-Seyahi,Izzet Fresko,Nurhan Seyahi,Yilmaz Ozyazgan,Cem Mat,Vedat Hamuryudan,Sebahattin Yurdakul,H. Yazici +7 more
TL;DR: The results suggest that the “disease burden” of Behçet syndrome is usually confined to the early years of its course, and in many patients the syndrome “burns out.”
Journal Article
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome
Vedat Hamuryudan,Cem Mat,S. Saip,Yilmaz Ozyazgan,Aksel Siva,Sebahattin Yurdakul,Kai Zwingenberger,H. Yazici +7 more
TL;DR: In this paper, the authors suggest that recurrent oral and genital ulcers are the most frequent problem in the management of the Behcet syndrome, and that thalidomide may help prevent recurrences.
Journal ArticleDOI
A double-blind trial of colchicine in Behçet's syndrome
Sebahattin Yurdakul,Cem Mat,Yalçın Tüzün,Yilmaz Ozyazgan,Vedat Hamuryudan,Omer Uysal,Mustafa Şenocak,H. Yazici +7 more
TL;DR: Colchicine may be useful for treating some of the manifestations of Behçet's syndrome, especially among women, and might be a reflection of less severe disease among the women.
Journal Article
Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melike Melikoglu,Izzet Fresko,Cem Mat,Yilmaz Ozyazgan,Feride Gogus,Sebahattin Yurdakul,Vedat Hamuryudan,H. Yazici +7 more
TL;DR: Etanercept did not affect the pathergy reaction and the cutaneous response to MSU crystals, however, the drug was effective in suppressing most of the mucocutaneous manifestations of BD.
Journal ArticleDOI
Pulmonary arterial aneurysms in behçet's syndrome: a report of 24 cases
Vedat Hamuryudan,Sebahattin Yurdakul,F. Moral,Furuzan Numan,Hasan Tüzün,Nukhet Tuzuner,Cem Mat,Yalçın Tüzün,Yilmaz Ozyazgan,Halil Yazici +9 more
TL;DR: As is true with other severe manifestations of Behçet's syndrome, PAAs are more common among males and they are associated with a prevalence of thrombophlebitis and there is high mortality despite treatment.